Mindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cardiovascular |
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cancer, Company News |
QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Digital Pathology |
Proscia earned ISO 27001 certification, demonstrating the company’s compliance with a well-known information security management standard.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies, Gastrointestinal Infections |
Laboratory services company PathAI Diagnostics unveiled an AI-assisted LDT for the histologic scoring and staging of MASLD and MASH.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Covid 19 |
3EO Health announced the receipt of an FDA emergency use authorization (EUA) for its SARS-CoV-2 molecular test.
Read More